ReviewCancers2023
Selective RET Inhibitors (SRIs) in Cancer: A Journey from Multi-Kinase Inhibitors to the Next Generation of SRIs.
Liz Clark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewCancers2023
Liz Clark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.